92 results
Key Clinical Points for Rosacea #Management #Derm #PrimaryCare #Rosacea #Overview #TakeHome #NEJM
Rosacea #Management #Derm ... Overview #TakeHome #NEJM
Xanthomas in Familial Hypercholesterolemia #Clinical #PrimaryCare #Derm #Xanthomas #FamilialHypercholesterolemia #Hypercholesterolemia #NEJM
#PrimaryCare #Derm ... Hypercholesterolemia #NEJM
Acanthosis Nigricans and Insulin Resistance - A 27-year-old woman presented with a 2-year history of acanthosis
B) #Clinical #Derm ... Acanthosis #Nigricans #NEJM
Metformin 
Current Renal Dose Adjustments due to Risk of Lactic Acidosis 
> 60 No adjustment 
45-60
45-60 Monitor eGFR ... #Dosing #Dose #Pharmacology
Panel A shows a patient with erythematotelangiectatic rosacea, in which diffuse erythema and telangiectasia are present
#Clinical #Derm ... PrimaryCare #Rosacea #NEJM
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Dosing based on GFR ... #Dosing #Pain #Pharmacology
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
maximum dose eGFR ... recommended dose eGFR ... Metformin #CKD #pharmacology
Excoriated papules with honey-colored crusting were present on the abdomen, back (Panel A), arms, and legs.
#Clinical #Derm ... Microscopy #Rash #NEJM
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
#Medications #Pharmacology ... Impairment #CKD #Table #GFR
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... not initiate if eGFR ... not continue if eGFR ... #Metformin #Pharmacology